Our Mission

 

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare.

Q3 2022

Teleconference & webcast

16 November 2022

Replay

news

01/27/2023

PAION receives positive CHMP opinion recommending approval of remimazolam for...

PAION AG / Key word(s): Miscellaneous PAION receives positive...

Read more
01/27/2023

Ad hoc release: PAION receives positive CHMP opinion recommending approval of...

PAION receives positive CHMP opinion recommending approval of...

Read more
01/25/2023

Press release: Extraordinary General Meeting approves capital reductions and...

Extraordinary General Meeting approves capital reductions and...

Read more
To the newsroom

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.

 

Visit us on LinkedIn!
LinkedIn